Article: The neuropathological contribution of prenatal inflammation to schizophrenia

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleThe neuropathological contribution of prenatal inflammation to schizophrenia
AuthorsMeyer, U1
Weiner, I3
McAlonan, GM2
Feldon, J1
Keywordscerebrospinal fluid
cytokines
enthorinal cortex
hippocampus
immune system
infection
MRI
neurodevelopment
prevention
ventricles
Issue Date2011
PublisherExpert Reviews Ltd. The Journal's web site is located at http://www.future-drugs.com/loi/ern
CitationExpert Review Of Neurotherapeutics, 2011, v. 11 n. 1, p. 29-32 [How to Cite?]
DOI: http://dx.doi.org/10.1586/ern.10.169
AbstractMaternal infection and/or inflammation during pregnancy has been repeatedly shown to elevate the risk of schizophrenia and related psychotic disorders in offspring. However, the relative contribution of such immune-related prenatal insults to specific neuropathological outcomes in schizophrenia remains essentially unknown. The study by Ellman et al. is the first to explore whether prenatal levels of the proinflammatory cytokine, IL-8, are associated with the volume of specific brain regions in patients diagnosed with schizophrenia spectrum disorder. The authors provide new data to support a significant association between higher prenatal IL-8 levels in the second/third trimester of pregnancy and greater ventricular cerebrospinal fluid volume in adult schizophrenia spectrum cases. In addition, the results provide evidence for a significant relationship between higher prenatal IL-8 levels and lower volumes in the left entorhinal cortex and right posterior cingulate. The findings provided by Ellman et al., together with the results obtained in other epidemiological studies and experimental animal research, should encourage basic researchers and clinicians alike to make efforts towards the investigation of maternal immunomodulatory interventions that may help alleviate abnormal brain development and long-term psychotic illness in offspring. © 2010 Expert Reviews Ltd.
ISSN1473-7175
2011 SCImago Journal Rankings: 0.200
DOIhttp://dx.doi.org/10.1586/ern.10.169
ISI Accession Number IDWOS:000288581800009
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorMeyer, U
dc.contributor.authorWeiner, I
dc.contributor.authorMcAlonan, GM
dc.contributor.authorFeldon, J
dc.date.accessioned2011-07-27T01:34:48Z
dc.date.available2011-07-27T01:34:48Z
dc.date.issued2011
dc.description.abstractMaternal infection and/or inflammation during pregnancy has been repeatedly shown to elevate the risk of schizophrenia and related psychotic disorders in offspring. However, the relative contribution of such immune-related prenatal insults to specific neuropathological outcomes in schizophrenia remains essentially unknown. The study by Ellman et al. is the first to explore whether prenatal levels of the proinflammatory cytokine, IL-8, are associated with the volume of specific brain regions in patients diagnosed with schizophrenia spectrum disorder. The authors provide new data to support a significant association between higher prenatal IL-8 levels in the second/third trimester of pregnancy and greater ventricular cerebrospinal fluid volume in adult schizophrenia spectrum cases. In addition, the results provide evidence for a significant relationship between higher prenatal IL-8 levels and lower volumes in the left entorhinal cortex and right posterior cingulate. The findings provided by Ellman et al., together with the results obtained in other epidemiological studies and experimental animal research, should encourage basic researchers and clinicians alike to make efforts towards the investigation of maternal immunomodulatory interventions that may help alleviate abnormal brain development and long-term psychotic illness in offspring. © 2010 Expert Reviews Ltd.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationExpert Review Of Neurotherapeutics, 2011, v. 11 n. 1, p. 29-32 [How to Cite?]
DOI: http://dx.doi.org/10.1586/ern.10.169
dc.identifier.citeulike8599475
dc.identifier.doihttp://dx.doi.org/10.1586/ern.10.169
dc.identifier.epage32
dc.identifier.hkuros187261
dc.identifier.isiWOS:000288581800009
dc.identifier.issn1473-7175
2011 SCImago Journal Rankings: 0.200
dc.identifier.issue1
dc.identifier.pmid21158552
dc.identifier.scopuseid_2-s2.0-78650359084
dc.identifier.spage29
dc.identifier.urihttp://hdl.handle.net/10722/135406
dc.identifier.volume11
dc.languageeng
dc.publisherExpert Reviews Ltd. The Journal's web site is located at http://www.future-drugs.com/loi/ern
dc.publisher.placeUnited Kingdom
dc.relation.ispartofExpert Review of Neurotherapeutics
dc.relation.referencesReferences in Scopus
dc.subjectcerebrospinal fluid
dc.subjectcytokines
dc.subjectenthorinal cortex
dc.subjecthippocampus
dc.subjectimmune system
dc.subjectinfection
dc.subjectMRI
dc.subjectneurodevelopment
dc.subjectprevention
dc.subjectventricles
dc.titleThe neuropathological contribution of prenatal inflammation to schizophrenia
dc.typeArticle
Author Affiliations
  1. Eidgenossische Technische Hochschule Zurich
  2. The University of Hong Kong
  3. Tel Aviv University